4 news items
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
MRVI
13 May 24
and custom materials, including its patented CleanCap® mRNA capping technology. Pharmaceutical leaders, biotech disruptors, and world governments
Where Maravai LifeSciences Stands With Analysts
MRVI
9 May 24
of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
MRVI
18 Apr 24
with custom mRNA synthesis, supported 350+ programs in biopharma development pipelines, and delivered over 100 GMP mRNA manufacturing batches
Small-Cap Maravai LifeSciences' Q4 Outperforms Expectations, Analyst shows Optimism Around 2024 Guidance
MRVI
23 Feb 24
forecasted demand for our Nucleic Acid Production products, including for CleanCap and custom chemistry,” said Trey Martin, Chief Executive Officer
- Prev
- 1
- Next